Amyris Inc. [NASDAQ: AMRS] closed the trading session at $2.06 on 12/19/22. The day’s price range saw the stock hit a low of $1.99, while the highest price level was $2.20. The company report on November 30, 2022 that AMYRIS CONSUMER BRANDS DELIVER 80% CYBER MONDAY LIKE-FOR-LIKE GROWTH.
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-MarketTM technology platform today announced continued year-over-year growth on Cyber Monday, November 28, 2022.
Amyris consumer brands saw 80% year-over-year growth in its direct-to-consumer (DTC) channel during this year’s Cyber Monday shopping event. The growth is based on a like-for-like (LFL) comparison and reflects brands that were actively selling to consumers at the same time last year. Cyber Monday’s sales performance was a continuation of the strong momentum seen during Black Friday week which was communicated earlier this week on November 28. The newer Amyris brands also delivered strong Cyber Monday sales performance.
The stocks have a year to date performance of -61.92 percent and weekly performance of 28.75 percent. The stock has been moved at -1.44 percent over the last six months. The stock has performed -2.83 percent around the most recent 30 days and changed -40.97 percent over the most recent 3-months.
If compared to the average trading volume of 5.70M shares, AMRS reached to a volume of 11505174 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Amyris Inc. [AMRS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMRS shares is $7.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRS stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Amyris Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 10, 2022. The new note on the price target was released on November 09, 2022, representing the official price target for Amyris Inc. stock. Previously, the target price had yet another drop from $4 to $2, while ROTH Capital kept a Neutral rating on AMRS stock.
The Average True Range (ATR) for Amyris Inc. is set at 0.21, with the Price to Sales ratio for AMRS stock in the period of the last 12 months amounting to 2.20.
AMRS stock trade performance evaluation
Amyris Inc. [AMRS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.75. With this latest performance, AMRS shares dropped by -2.83% in over the last four-week period, additionally sinking by -1.44% over the last 6 months – not to mention a drop of -62.27% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRS stock in for the last two-week period is set at 53.72, with the RSI for the last a single of trading hit 61.79, and the three-weeks RSI is set at 49.91 for Amyris Inc. [AMRS]. The present Moving Average for the last 50 days of trading for this stock 2.2000, while it was recorded at 1.8200 for the last single week of trading, and 2.8300 for the last 200 days.
Amyris Inc. [AMRS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Amyris Inc. [AMRS] shares currently have an operating margin of -48.31 and a Gross Margin at +51.77. Amyris Inc.’s Net Margin is presently recorded at -79.12.
Return on Equity for this stock declined to -679.38, with Return on Assets sitting at -45.95.
Amyris Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.50 and a Current Ratio set at 0.90.
Earnings per share (EPS) analysis for Amyris Inc. [AMRS] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amyris Inc. go to 30.00%.
Amyris Inc. [AMRS]: Insider Ownership positions
There are presently around $243 million, or 38.90% of AMRS stock, in the hands of institutional investors. The top three institutional holders of AMRS stocks are: VANGUARD GROUP INC with ownership of 19,793,472, which is approximately 3.737% of the company’s market cap and around 0.70% of the total institutional ownership; BLACKROCK INC., holding 13,269,048 shares of the stock with an approximate value of $27.33 million in AMRS stocks shares; and VIVO CAPITAL, LLC, currently with $15.97 million in AMRS stock with ownership of nearly -33.425% of the company’s market capitalization.
Positions in Amyris Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 102 institutional holders increased their position in Amyris Inc. [NASDAQ:AMRS] by around 11,385,607 shares. Additionally, 88 investors decreased positions by around 33,069,834 shares, while 50 investors held positions by with 73,299,665 shares. The mentioned changes placed institutional holdings at 117,755,106 shares, according to the latest SEC report filing. AMRS stock had 25 new institutional investments in for a total of 1,853,173 shares, while 36 institutional investors sold positions of 10,787,065 shares during the same period.